Its generally safer and more sustainable long-term than stimulant-based weight loss drugs.
The authors conclude that this antioxidant-based support is well tolerated and may provide clinically meaningful benefits, although controlled trials are needed to confirm efficacy ( Weight of evidence: Overall evidence is Low : primarily preclinical with heterogeneous designs and no consistent human biomarkers
The questions that remain unanswered include the actual prevalence of sexual side effects (we do not know if it affects 5 percent or 30 percent of women), whether certain doses are more likely to cause sexual dysfunction than others, whether compounded semaglutide formulations produce different sexual side effect profiles than brand-name versions, whether specific pharmacy sources or compounding pharmacies produce formulations with different tolerability profiles, and whether pre-treatment screening can identify women at higher risk for sexual dysfunction on GLP-1 agonists
Its phenomenal at evening out skins tone and texture, and just makes you glow like you wouldnt believe
The dual GIP/GLP-1 mechanism may provide enhanced appetite control and metabolic benefits beyond what semaglutide's single-receptor action achieves
The following is a research schedule , not a prescription